Schedule 13G ownership disclosure

Petros Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 71678J100

Event date: 2021-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
103,474
Percent of class
4.1800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000930413-22-000316
Form type
SC 13G/A
Filer
Iroquois Capital Management, LLC
CIK
CIK 1481867
Filed
Feb 23, 2022
Reporting period
Dec 31, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub